Silence Therapeutics SLN
NASDAQ SLN
$14.62 -0.17 (-1.15%)
As of: Sep 4, 2026 · 2:23 PM EDT

Silence Therapeutics (SLN) FCF Margin (QoQ) (2024 - 2026)

Analysis

Silence Therapeutics (SLN) FCF Margin (QoQ) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn
5 Revolution Medicines 44.07 Bn 44.07 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn
10 Silence Therapeutics 691.07 Mn 618.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.64 Mn
Dec 31, 2025 -4.54 Mn
Sep 30, 2025 509,990.00
Jun 30, 2025 -118,231.00
Mar 31, 2025 -849,400.00
Dec 31, 2024 157,902.00
Sep 30, 2024 -104,678.00
Jun 30, 2024 -58,576.00